Prehypertension: Detection, evaluation, and management
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Prehypertension was defined as a discrete category in 1993. There is evidence to support active management of this entity given the increased risk of hypertension, cardiovascular disease, heart failure, and stroke. There have been few comprehensive summaries on the management of this population. Therefore, this article summarizes the latest guidelines and studies on the detection, evaluation, and management of prehypertension.
- Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252. CrossRef
- Hsia J, Margolis KL, Eaton CB, et al.: Prehypertension and cardiovascular disease risk in the Women’s Health Initiative. Circulation 2007, 115:855–860. CrossRef
- Kshirsagar AV, Carpenter M, Bang H, et al.: Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006, 119:133–141. CrossRef
- Qureshi AI, Suri MF, Kirmani JF, et al.: Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005, 36:1859–1863. CrossRef
- Vasan RS, Larson MG, Leip EP, et al.: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291–1297. CrossRef
- Zhang Y, Lee ET, Devereux RB, et al.: Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006, 47:410–414. CrossRef
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413–2446.
- Qureshi AI, Suri MF, Kirmani JF, Divani AA: Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 2005, 11:CR403–409.
- Wang Y, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines. Arch Intern Med 2004, 164:2126–2134. CrossRef
- Vasan RS, Beiser A, Seshadri S, et al.: Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002, 287:1003–1010. CrossRef
- Leitschuh M, Cupples LA, Kannel W, et al.: High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991, 17:22–27.
- Vasan RS, Larson MG, Leip EP, et al.: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001, 358:1682–1686. CrossRef
- Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913. CrossRef
- US Department of Agriculture. The report of the Dietary Guidelines Advisory Committee on Dietary Guidelines for Americans, 2005. Available at http://www.health.gov/DietaryGuidelines/dga2005/report/default.htm. Accessed May 2007.
- Law MR, Frost CD, Wald NJ: By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. BMJ 1991, 302:819–824. CrossRef
- Midgley JP, Matthew AG, Greenwood CM, Logan AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996, 275:1590–1597. CrossRef
- Graudal NA, Galloe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998, 279:1383–1391. CrossRef
- Cutler JA, Follmann D, Allender PS: Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997, 65:643S–651S.
- He FJ, MacGregor GA: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002, 16:761–770. CrossRef
- Hooper L, Bartlett C, Smith GD, Ebrahim S: Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002, 5:628–632. CrossRef
- Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003, 17:471–480. CrossRef
- Cook NR, Cutler JA, Obarzanek E, et al.: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ 2007, 334:885–888. CrossRef
- The Trials of Hypertension Prevention Collaborative Research Group: The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, phase I. JAMA 1992, 267:1213–1220. CrossRef
- The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997, 157:657–667. CrossRef
- He FJ, MacGregor GA: How far should salt intake be reduced? Hypertension 2003, 42:1093–1099. CrossRef
- Sacks FM, Svetkey LP, Vollmer WM, et al.: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASHSodium Collaborative Research Group. N Engl J Med 2001, 344:3–10. CrossRef
- Mattes RD: The taste for salt in humans. Am J Clin Nutr 1997, 65:692S–697S.
- Cappuccio FP, MacGregor GA: Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991, 9:465–473. CrossRef
- Whelton PK, He J, Cutler JA, et al.: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997, 277:1624–1632. CrossRef
- He FJ, Markandu ND, Coltart R, et al.: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension 2005, 45:571–574. CrossRef
- Appel LJ, Moore TJ, Obarzanek E, et al.: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336:1117–1124. CrossRef
- Appel LJ, Sacks FM, Carey VJ, et al.: Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005, 294:2455–2464. CrossRef
- Ebrahim S, Smith GD: Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions. J Public Health Med 1998, 20:441–448.
- Neter JE, Stam BE, Kok FJ, et al.: Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003, 42:878–884. CrossRef
- He J, Whelton PK, Appel LJ, et al.: Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000, 35:544–549.
- Lee M, Aronne LJ: Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol 2007, 99:68B–79B. CrossRef
- Halbert JA, Silagy CA, Finucane P, et al.: The effectiveness of exercise training in lowering blood pressure: a meta-analysis of randomised controlled trials of 4 weeks or longer. J Hum Hypertens 1997, 11:641–649. CrossRef
- Whelton SP, Chin A, Xin X, He J: Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002, 136:493–503.
- Cornelissen VA, Fagard RH: Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005, 46:667–675. CrossRef
- Klatsky AL: Alcohol, coronary disease, and hypertension. Annu Rev Med 1996, 47:149–160. CrossRef
- McFadden CB, Brensinger CM, Berlin JA, Townsend RR: Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens 2005, 18:276–286. CrossRef
- Xin X, He J, Frontini MG, et al.: Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001, 38:1112–1117. CrossRef
- Nissen SE, Tuzcu EM, Libby P, et al.: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004, 292:2217–2225. CrossRef
- Julius S, Nesbitt SD, Egan BM, et al.: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006, 354:1685–1697. CrossRef
- Meltzer JI: A specialist in clinical hypertension critiques the TROPHY trial. Am J Hypertens 2006, 19:1098–1100. CrossRef
- Appel LJ, Champagne CM, Harsha DW, et al.: Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003, 289:2083–2093. CrossRef
- Elmer PJ, Obarzanek E, Vollmer WM, et al.: Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006, 144:485–495.
- Bavikati V, Sperling L, Salmon R, et al.: Clinical effectiveness of therapeutic lifestyle changes in patients with prehypertension [abstract]. J Cardiopulm Rehabil 2006, 26:267. CrossRef
- Prehypertension: Detection, evaluation, and management
Current Treatment Options in Cardiovascular Medicine
Volume 10, Issue 4 , pp 273-282
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links